Phase I trial of CNV 2197944

Trial Profile

Phase I trial of CNV 2197944

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Nov 2011

At a glance

  • Drugs CNV 2197944 (Primary)
  • Indications Musculoskeletal pain; Neuropathic pain
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 21 Nov 2011 Status changed from recruiting to completed, according to a Convergence Pharmaceuticals media release.
    • 21 Apr 2011 Planned End Date changed to 30 Sep 2011, according to a Convergence Pharmaceuticals media release.
    • 21 Apr 2011 Status changed from planning to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top